Salute e Benessere
Trillion-Dollar Digital Healthcare Transformations Shaped by AI, Quantum and Biotech Breakthroughs at GITEX GLOBAL
From 13-17 October 2025 , the 45th edition of the world's largest tech and AI show united 6,800 exhibitors, 2,000 startups, and delegations from 180 nations, with digital health and biotech emerging as some of the most dynamic narratives of the week. From genome editing to neurotech and quantum medicine, became the platform where the world's brightest minds explored how technology is fundamentally rewriting the science of life.
On the GITEX main stage, Trevor Martin , CEO and Co-Founder of Mammoth Biosciences, captured imaginations with his vision of "rewriting the code of life." Demonstrating how AI and CRISPR technologies can accelerate gene-editing therapies, he revealed,
Neurotech pioneer, Matt Angle , CEO of Paradromics, revealed progress from the world's first successful brain-computer implant and high data brain-computer interface.
In Ashley Zehnder , CEO of Fauna Bio, demonstrated how the study of mammal genomes is opening an untapped library of new drug discoveries.
With global pharmaceutical R&D costs averaging US$2.23 billion per asset as per Deloitte, innovation in this field has long been limited by time and resources. At , Jack Hidary , CEO of SandboxAQ, introduced a game-changing solution: quantum algorithms capable of compressing research timelines from decades to months.
The dialogue extended from lab-scale to system-level reform in a session titled where Dimitris Moulavasilis, Group CEO of M42, and Dr. Georges-Pascal Haber , CEO of Cleveland Clinic, called for a complete system overhaul in how healthcare is funded and delivered.
Meanwhile, Ramin Hasani , CEO of Liquid AI, unveiled liquid neural networks - architectures inspired by the brains of microscopic worms - capable of learning and adapting in real time, mirroring the flexibility of living intelligence.
The breakthroughs unveiled at GITEX GLOBAL 2025 set a new benchmark for how technology, biology and wellness converge into scalable solutions for real-world impact.
captivated audiences with six smart contact-lens prototypes, integrating augmented reality and biosensing to monitor glucose levels and overlay real-time data in the wearer's field of view — a bold step toward wearable, always-on medical computing.
unveiled an AI-powered behavioural analysis tool designed to bring greater precision to autism screening and tracking developmental progress; a breakthrough in a field that continues to face gaps in scientific understanding and diagnostic consistency. Meanwhile, South Korean startup introduced its AI-powered SaaS enabling precision medicine for one million patients with chronic conditions.
debuted a GenAI-driven discovery platform that reimagines how antibodies are designed and developed, which could drastically shorten the pharmaceutical R&D cycle and accelerate breakthroughs in precision immunotherapy.
showcased the Sonic Pill®, a breakthrough in sound-based wellness technology that uses precision audio frequencies and neuroscience-driven algorithms to enhance sleep, focus, recovery, and cognitive performance. Winner of 'The Best Invention' FIRI Award in Korea and Silver Medal for Sound Therapy Innovation at ARCA Croatia, the wearable device redefines how sound can be harnessed to elevate human health and wellbeing.
For more information, visit: www.gitex.com
#GITEXGLOBAL
Photo: https://mma.prnewswire.com/media/2810279/Trevor_CEO_MammothBioscience.jpg
View original content:https://www.prnewswire.co.uk/news-releases/trillion-dollar-digital-healthcare-transformations-shaped-by-ai-quantum-and-biotech-breakthroughs-at-gitex-global-302609963.html